| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 04/23/2008 | EP1912950A2 Preparation of 4,5-diamino-1-(substituted)-pyrazole and acid addition salts thereof |
| 04/23/2008 | EP1912497A1 Fungicidal n-[2-(haloalkoxy)phenyl]heteroarylcarboxamides |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | CN101166733A Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 04/23/2008 | CN101166728A Method for producing alkyl anilides |
| 04/23/2008 | CN101166727A Process for preparing substituted 1-[3-(pyrazolyl)phenyl]-3-phenyl ureas |
| 04/23/2008 | CN101165055A Method for preparing 5-amino-3-cyano-4-thiocyano-1-(2,6-dichloro-4-fluoromethylphenyl)pyrazole |
| 04/23/2008 | CN101165048A Method for preparing polyisocyanic acid ester |
| 04/23/2008 | CN100383145C 4-biphenyl-substituted 4-substituted pyrazolidin-3,5-diones pesticide agent and/or microbicide and/or herbicide |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/22/2008 | US7361769 Metabolic disorders, eating disorders such as hyperphagia, and diabetes |
| 04/22/2008 | US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 04/22/2008 | US7361672 Pyrazoles, triazoles, or tetrazoles substituted with an aryl- or heteroarylcarbonylamino group and an aminocarbonylmethyl group: 5-chloro-thiophene-2-carboxylic acid (1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-1H-[1,2,4]triazol-3-yl)-amide; improved selectivity towards thrombin |
| 04/22/2008 | CA2210693C Pyrazol-4-yl-benzoyl derivatives and their use as herbicides |
| 04/17/2008 | WO2008045529A1 Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases |
| 04/17/2008 | WO2008045371A2 N-substituted-azacyclylamines as histamine-3 antagonists |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008043789A1 Novel compounds |
| 04/17/2008 | WO2008043788A2 Novel compounds |
| 04/17/2008 | WO2008043567A1 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 04/17/2008 | WO2008043544A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 04/17/2008 | WO2008022777A3 Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives |
| 04/17/2008 | WO2008021933A3 N-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors |
| 04/17/2008 | WO2008017932A3 Heterocycles useful as inhibitors of carbonic anhydrase |
| 04/17/2008 | WO2008014905A3 3-difluoromethylpyrazolylcarboxanilides |
| 04/17/2008 | WO2007147771A3 Tetralin and indane derivatives and uses thereof |
| 04/17/2008 | US20080091027 React azole derivative in hydrocarbon, ether solvent at mild temperaturein the presence of a catalytic iridium boron cyclooctadiene complex; intermediates to natural and synthetic functionalized compounds; cytotoxic, anticancer and antiviral agents |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090882 Heterocyclic Carbonyl Compounds |
| 04/17/2008 | US20080090880 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators |
| 04/17/2008 | US20080090875 Analgesics, antipyretics, antiinflammatory agents; 4-(4-chlorophenyl)-5-(4-methanesulfonylphenyl)-1,2-dihydropyrazole-3-thione for example; cyclooxygenase-2 (COX-2) inhibitors; side effect reduction |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090809 Pyrazole compounds |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/17/2008 | CA2665071A1 N-substituted-azacyclylamines as histamine-3 antagonists |
| 04/16/2008 | EP1911762A1 Amino alcohols and their use as renin inhibitors |
| 04/16/2008 | EP1911747A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators |
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |
| 04/16/2008 | EP1910391A1 Processes for preparing pyrazole-o-glycoside derivatives and novel intermediates of said processes |
| 04/16/2008 | EP1910332A2 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 04/16/2008 | EP1910331A1 PYRAZOLE DERIVATIVES AS CBl MODULATORS |
| 04/16/2008 | EP1910317A1 1-amino linked compounds |
| 04/16/2008 | EP1910312A1 Quadratic acid ii derivatives |
| 04/16/2008 | EP1910304A2 Therapeutic agents |
| 04/16/2008 | EP1910303A2 Process for synthesizing a substituted pyrazole |
| 04/16/2008 | EP1910302A1 Carbonyl substituted pyrazoline compounds, their preparation and use as cb1 receptor modulators |
| 04/16/2008 | EP1910301A2 Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/16/2008 | EP1910300A2 Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 04/16/2008 | EP1910299A1 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 04/16/2008 | CN101163679A Method of preparing ultrapure 4-methylpyrazole |
| 04/16/2008 | CN101163669A Acetylene derivatives |
| 04/16/2008 | CN101163662A Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381425C 6-amino-1H-indazole and its pharmaceutical compositions as phosphodiesterase 4 inhibitors, and use thereof |
| 04/15/2008 | US7358393 Method for preparing β-alaninamides |
| 04/15/2008 | US7358387 novel 2-dihaloacyl-3-aminoacrylic esters by reacting acid halides with dialkylaminoacrylic esters, to their use for preparing 3-dihalomethylpyrazoles; high overall yield and high purity and can be converted with high selectivity to the desired 3-dihalomethylpyrazole-4-carboxylic esters |
| 04/15/2008 | US7358371 Process for the preparation of 1,5—carboxylic acid derivatives |
| 04/15/2008 | US7358370 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358214 [5-fluoro-1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-N-[2-(1-hydroxy-1-methylhexyl)phenyl]carboxamide and its derivatives as bactericide, fungicide, herbicide |
| 04/15/2008 | CA2411468C Thrombopoietin mimetics |
| 04/10/2008 | WO2008042388A1 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/10/2008 | WO2007144327A3 Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands |
| 04/10/2008 | WO2007137874A3 Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such |
| 04/10/2008 | US20080085924 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 04/10/2008 | US20080085904 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant |
| 04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |
| 04/10/2008 | US20080085899 Tetrahydrothiopyrano pyrazole cannabinoid modulators |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/10/2008 | CA2664398A1 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/09/2008 | EP1907365A1 Salts of substituted pyrazoline compounds, their preparation and use as medicaments |
| 04/09/2008 | EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 04/09/2008 | EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials |
| 04/09/2008 | CN101160128A Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient |
| 04/09/2008 | CN100379727C Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation |
| 04/08/2008 | US7355081 androgen receptor antagonists; certain cancers, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired |
| 04/08/2008 | US7354946 Biarylurea derivatives |
| 04/08/2008 | US7354938 4[2(2,4chlorophenyl)pyrazol]-phenyl-cyclopropan; 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor; antidiabrtic agent, obesity, insulin resistance; improved physicochemical (stability) and biological (activity to inhibit HSD1, specificity, bioavailability, metabolism) |
| 04/03/2008 | WO2008039645A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2008016883A3 Inhibitors of plasma kallikrein |
| 04/03/2008 | WO2008014199A3 Sulfonyl compounds which modulate the cb2 receptor |
| 04/03/2008 | US20080081833 1-(5-cyclopropyl-2-phenyl-2H-pyrazol-3-yl)-3-(4-ethoxyphenyl)urea; 1-(5-cyclopropyl-2-phenyl-2H-pyrazol-3-yl)-3-(4-ethoxyphenyl)urea; anxiolitic and antidepressant agent; myasthenia gravis, neurodegenerative disorders, nicotine addiction |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | US20080081807 Arylphenyl-substituted cyclic keto-enols |
| 04/03/2008 | US20080078303 Magenta chromophore dyes stabilized by adding steric hindering groups to protect the imino carbons; (phenyl, methyl, ethyl, isopropyl, fluoride, chloride, bromide and iodide groups); azo dyes; quality and photostability particularly when trying to reproduce the color gamut of silver halide prints |
| 04/03/2008 | CA2664310A1 Compounds which modulate the cb2 receptor |
| 04/02/2008 | EP1905762A1 Pyrazolone derivative |
| 04/02/2008 | EP1904496A2 Compositions and methods pertaining to pna synthons and oligomers comprising a universal base |
| 04/02/2008 | EP1904452A2 Histone deacetylase inhibitors |
| 04/02/2008 | EP1904451A1 Aryl-alkylamines and heteroaryl-alkylamines as protein kinase inhibitors |
| 04/02/2008 | EP1904450A1 Pyrazole-4- carboxamide derivatives as microbiocides |
| 04/02/2008 | CN101155789A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 04/02/2008 | CN101155783A Pyrazoles |
| 04/02/2008 | CN101155583A 有丝分裂驱动蛋白的抑制剂 Mitotic kinesin inhibitors |
| 04/02/2008 | CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives |
| 04/02/2008 | CN100377645C Substituted arylpyrazoles as parasiticidal agents |
| 04/01/2008 | US7351841 Heterocyclic compounds and thrombopoietin receptor activators |
| 04/01/2008 | US7351831 Process for asymmetric intramolecular [3+2] cyclo-addition of hydrazones |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351822 Serine protease inhibitors |